Posbank Co.,Ltd. (KOSDAQ:105760)
4,460.00
-180.00 (-3.88%)
At close: Oct 30, 2026
Posbank Revenue
Posbank had revenue of 36.61B KRW in the quarter ending June 30, 2026, with 40.99% growth. This brings the company's total for the last twelve months to 107.43B, up 23.32% year-over-year. In the year 2025, Posbank had annual revenue of 91.43B with 18.61% growth. That makes Posbank the 24,359th largest company in the world by revenue and 1,398th in South Korea.
Revenue (ttm)
107.43B
Revenue Growth
+23.32%
P/S Ratio
0.42
Revenue / Employee
866.37M
Employees
124
Market Cap
45.56B
Revenue by Geography
- United States 36.16B 39.5%
- Korea 20.47B 22.4%
- Italy 7.67B 8.4%
- Malaysia 4.66B 5.1%
- Japan 3.30B 3.6%
- India 2.85B 3.1%
- United Arab Emirates 2.52B 2.8%
- Other 13.79B 15.1%
Fiscal year ended Dec 31, 2025 See the full Posbank breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 91.43B | 14.34B | 18.61% |
| Dec 31, 2024 | 77.08B | -2.20B | -2.78% |
| Dec 31, 2023 | 79.28B | -12.20B | -13.34% |
| Dec 31, 2022 | 91.49B | -7.96M | -0.01% |
| Dec 31, 2021 | 91.50B | 29.75B | 48.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Woowon Development | 315.10B |
| A-Tech Solution | 304.86B |
| SCD Co., Ltd. | 203.08B |
| RP Bio | 141.42B |
| Jin Yang Pharmaceutical | 124.61B |
| Kocom | 104.02B |
| HCT Co., Ltd. | 103.00B |
| GeneBioTech Co. ,Ltd | 89.31B |